Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among interventionalists for treating calcified plaque inside coronary and peripheral arteries ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.Â
-
-
Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease, presented the results of the first 95 patients treated in the POWER PAD II U.S ...
-
One Year Data Shows Durable Performance and Safety of the Shockwave Javelin Peripheral IVL CatheterÂNov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave Javelin Peripheral IVL Catheter, a novel Forward IVL platform designed to modify ...
-
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, will present 30-day results of its POWER PAD ...
Jan. 27, 2026 — Robocath has launched the world’s first FIH (First-In-Human) clinical study evaluating its new robotic ...
January 27, 2026
Dec. 10, 2025 — Medtronic plc has announced the first commercial use of the Liberant thrombectomy system (Liberant) ...
January 07, 2026
Dec. 15, 2025 — Royal Philips has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in enhanced ...
December 15, 2025
Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...
November 14, 2025
Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease ...
November 09, 2025
One Year Data Shows Durable Performance and Safety of the Shockwave Javelin Peripheral IVL CatheterÂ
Nov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave ...
November 06, 2025
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...
September 12, 2025
June 6, 2025 – A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 ...
June 06, 2025
Feb. 3, 2025 — Today, Peripheral Artery Disease (PAD) affects 10 million Americans and is the most common cause of limb ...
February 04, 2025
Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD) ...
January 13, 2025
A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more ...
January 13, 2025
Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...
December 16, 2024
Nov. 18, 2024 — In November, Esperion presented  an analysis from the CLEAR Outcomes study focused on patients with ...
December 03, 2024
Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...
November 08, 2024
Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...
September 16, 2024